Leading growth of Alto Technologies to enable best-in-class distribution across biopharmaceutical, medical technology, hubs, pharmacies and payers.

Lead BD and operations for Lingo. Lingo Biowearables is a new category of health tech that measures your body’s biomarkers in real-time. Biowearables help us learn about our bodies at a deeper level to improve and guide the way we eat, sleep, train and even prevent diseases. By bringing this leading-edge technology to the consumer market, we can help hundreds of millions of people live healthier and fuller life.

Abbott New Analyte Ventures is using the FreeStyle Libre CGM core technology to address new molecules (beyond glucose) and new conditions (beyond diabetes) where continuous biomarker measurement and real-time feedback can improve customer and patient lives.

Leading the US digital health business for Abbott Diabetes Care

Leading the strategy and launch of Abbott Diabetes Care's digital health business.

Advise, inform and drive the growth and development of the firm. Led digital health strategy development and digital solution launches for major biopharmaceutical, medical device and life science companies.

Medullan's Digital Strategy Practice brings a value-driven perspective to the table. Through our combined knowledge and decades of experience with the entire healthcare continuum we evaluate opportunities for digital health and rapidly validate digital concepts using qualitative ecosystem engagement and aligning with internal commercial plans and measures. We combine this lean approach to strategy development with innovative partnership strategies and extensive return on investment and monetization models. This delivers a cohesive product, commercialization and business strategy for digital innovation that brings clarity and maximizes value for our clients.Specifically, I lead the development of proprietary business models and monetization strategies around innovative digital health products, services and programs for IDNs, diagnostic services, biopharmaceuticals, health technology and life sciences clients. Specializing in digital health market access for wellness/prophylatics, RWE collection/analytics, diagnostics and therapeutics, I leverage my background in venture capital, finance, asset securitization, healthcare delivery business development/ROI analysis and entrepreneurship to innovate and implement new business models around innovative technologies. Published here: http://electronichealthreporter.com/shift-value-demands-real-world-data/

Privia builds and enables high-performance physician groups and clinically integrated provider networks – using technology, team-based care, and unique wellness programs to help leading doctors better manage the health of their populations.

8 Rivers Capital is a private equity firm that brings new ideas to market, with the goal of solving big world problems with innovative solutions. Thesis of developing disruptive, IP-protected innovations in capital intensive, inefficient industries raising strategic capital.Source, diligence, and execute venture opportunities over a variety of disciplines. Independently guided work on early stage companies targeting technology oriented >$1bn economic opportunities.Lead Principal on ParkInuit. For more information, visit: http://www.parkintuit.com

ChangeEducate was a unique non-profit start-up focused on educating high school students on poverty, development, and social entrepreneurship through a DVD-based curriculum accompanied with lesson plans and an interactive website. Scheduled for nationwide distribution in spring of 2013 with high accolades from pilot schools.Founded and grew organization, oversaw 3 key milestones:- Fundraised $35k+ from the Pepsi, MTV, the Prudential Foundation, and more- Designed and developed core products DVD, curricula and website - Beginning of product launch in 30 schools throughout 2012.

GE Power and Water

GE Trading - Research & Marketing